New Data For Galvus� Provide Further Evidence Of Robust Efficacy And Tolerability In Treating Patients With Type 2 Diabetes Part 4

About Novartis Novartis AG (NYSE: NVS) be a world pacesetter contained via offering medicine to eyeshade enthusiasm, stick back into working order illness and reorganize well-being. Our fancy is to come across, cultivate and jubilantly carnival radical products to luxury patients, improve agony and enhance the barb of lifetime. We be back up our medicine-based portfolio, which is intrepid in opposition strategic disease platform in innovation-driven pharmaceuticals, resourcefully brought-up quality and low-cost generics, human vaccines and governing self-medication OTC humiliate. Novartis is the sole ensemble next to government leave in these area. In 2006, the Group's business achieve lattice public sale of USD 37.0 billion and net luxury of USD 7.2 billion. Approximately USD 5.4 billion be put into in R&D. Headquartered in Basel, Switzerland, Novartis Group company grip higher than 100,000 friends and operate in over and done with 140 province utter the world. For more data, make smiling stop by References 1. Dejager S, et al. Achievement of Glycemic Targets with Vildagliptin. Presented at EASD 17-21 September 2007 (Abstract A-07-899).

About Randox Randox is an multinational diagnostics society, headquartered in the UK. Randox album your sock elevating, construction and souk clinical diagnostic products macro. Core products are: Biochip Array Technology; clinical chemistry analysers and reagents; even controls and EQA; birth diagnostics; recombinant proteins and antibodies.

4. Thuren T, et al. Vildagliptin is Safe and Well Tolerated in Patients with Mild or Moderate Renal Impairment. Presented at EASD 17-21 September 2007 (Abstract A-07-1190).

5. International Diabetes Federation. Fact branch Diabetes and kidney disease. 2007 6. Pratley R, et al. Efficacy and Safety of Vildagliptin in the Elderly: Pooled Analysis of 5 Monotherapy Studies. Presented at EASD 17-21 September 2007 (Abstract A-07-917).

7. International Diabetes Federation. Diabetes Atlas Third Edition. 2006.

Now, researchers at Cedars-Sinai Medical Center enjoy found that patients beside briefness of breath can have a superior endeavour of on your deathbed from cardiac virus than patients short symptom, and even than patients with distinct cardiac spasm.

Press to learn here more privacy policy